Preferred Label : Daunorubicinol;
NCIt synonyms : 13-Dihydrodaunomycin; 13-Hydroxydaunomycin; Daunomycinol; 13-Dihydrodaunorubicin; Leukaemomycin D; Duborimycin; Daunorubicineal; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,
9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-;
NCIt definition : An anthracycline antineoplastic antibiotic with therapeutic effects similar to those
of doxorubicin. Daunorubicinol exhibits cytotoxic activity through topoisomerase-mediated
interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein
synthesis. (NCI04);
UNII : YDU8YIP30L;
CAS number : 28008-55-1;
NSC code : 180510;
Origin ID : C1062;
UMLS CUI : C0057159;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- has_salt_form
- is_component_of_chemotherapy_regimen
- is_free_acid_or_base_form_of
